CCI initiates Pharma sector study, to begin consultation process with cos, doctors, chemists, pharma cos, Here is how to participate
New Delhi: With a view to developing a better understanding of the competition landscape in the sector, the Competition Commission of India ('CCI') is conducting a 'Market Study on the Pharmaceutical Sector in India
The watchdog, which keeps a tab on unfair business practices across sectors, started the market study on the domestic pharmaceutical sector in October last year.
"The study is being done with a view to developing a better understanding of the competition landscape in the sector," CCI has stated
"As part of the study, the CCI is conducting consultation with stakeholders (pharmaceutical companies, stockists, chemists, trade associations, doctors, sector experts and regulators).
" Any of the aforementioned stakeholders willing to participate in the consultation may please reach out to us at pharmastudy@cci.gov.in till 19th March, 2021," the CCI has stated
"The idea behind the consultation is to gather insights on issues that may have a bearing on competition in the pharmaceutical market in India," the regulator said in a public notice.
The current study is focussing on the distribution segment of the pharmaceutical market in India with a view to understanding discounts, margins, policies at wholesale and retail levels of the distribution system, the role of trade association vis-a-vis various aspects of the distribution business, impact of e-commerce on price and competition, among other aspects.
In December last year, CCI Chairperson Ashok Kumar Gupta had said that quality, access and affordability of medicines are the key determinants for the overall quality of public health.
However, owing to the inherited information asymmetry in consumers and suppliers for medicines, markets by themselves may not deliver optimal outcomes in terms of these parameters, he had said.
CCI has been conducting various market studies to understand competition issues in different sectors.
